Berapakah harga Handa Pharmaceuticals, Inc. (6620)

Harga Handa Pharmaceuticals, Inc. (6620) adalah $2.95

Apakah topi pasaran Handa Pharmaceuticals, Inc. (6620)

Cap pasaran Handa Pharmaceuticals, Inc. (6620) adalah $491.95M

Handa Pharmaceuticals, Inc. (6620) EPS

Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.

Tahun	EPS	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

EPS

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	EPS	Perbezaan EPS	Negara
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-	IN
Galderma Group AG GALD.SW	-	-	CH

Syarikat

EPS

Perbezaan EPS

Negara